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sodium arsenite induced autophagy in HK-2 cells at early 
phase (6 h) and the subsequent apoptosis at 24 h. Treatment 
by TMP or by the antioxidant N-acetylcysteine decreased 
arsenic-induced ROS production, enhanced GSH levels, 
prevented mitochondria dysfunction and suppressed the 
activation of pro-inflammatory signals and the development 
of autophagy and apoptosis. Our results suggested that TMP 
may be used as a new potential therapeutic agent to prevent 
arsenic-induced nephrotoxicity by suppressing these patho-
logical processes.
Keywords Sodium arsenite · Tetramethylpyrazine 
(TMP) · Nephrotoxicity · Mitochondrial dysfunction · 
Cyclooxygenase-2 · Autophagy
Abbreviations
AKI  Acute kidney injury
CKD  Chronic kidney disease
COX-2  Cyclooxygenase-2
DHE  Dihydroethidium
FACS  Fluorescence-activated cell sorter
GSH  Glutathione
MAPK  Mitogen-activated protein kinase
MTT  3-(4,5-Dimethylthiazol-2-yl)-2,5- 
diphenyltetrazolium
NAC  N-Acetylcysteine
NF-κB  Nuclear factor-κB
PARP  Poly ADP-ribose polymerase
PI  Propidium iodide
ROS  Reactive oxygen species
SDH  Succinate dehydrogenase
TMP  Tetramethylpyrazine
TNF-α  Tumor necrosis factor alpha
TUNEL  Terminal deoxynucleotidyl transferase-mediated 
dUTP-biotin nick-end labeling
Abstract Although kidney is a target organ of arsenic 
cytotoxicity, the underlying mechanisms of arsenic-induced 
nephrotoxicity remain poorly understood. As tetramethyl-
pyrazine (TMP) has recently been found to be a renal pro-
tectant in multiple kidney injuries, we hypothesize that TMP 
could suppress arsenic nephrotoxicity. In this study, human 
renal proximal tubular epithelial cell line HK-2 was used to 
elucidate the precise mechanisms of arsenic nephrotoxicity 
as well as the protective mechanism of TMP in these cells. 
Sodium arsenite exposure dramatically increased cellular 
reactive oxygen species (ROS) production, decreased levels 
of cellular glutathione (GSH), decreased cytochrome c oxi-
dase activity and mitochondrial membrane potential, which 
indicated mitochondrial dysfunction. On the other hand, 
sodium arsenite activated pro-inflammatory signals, includ-
ing β-catenin, nuclear factor-κB (NF-κB), p38 mitogen-acti-
vated protein kinase (MAPK), tumor necrosis factor alpha 
and cyclooxygenase-2 (COX-2). Small molecule inhibi-
tors of NF-κB and p38 MAPK blocked arsenic-induced 
COX-2 expression, suggesting arsenic-induced COX-2 up-
regulation was NF-κB- and p38 MAPK-dependent. Finally, 
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Introduction
Arsenic is a major environmental contaminant of global 
scale and arsenic exposure could result in cancer of the 
skin, liver, bladder, kidney and lung, as well as, cardiovas-
cular disease, developmental and reproductive abnormali-
ties (Michael 2013; Rodriguez-Lado et al. 2013; Yu et al. 
2013). In spite of its adverse health effects, short-term, 
acute arsenic exposure has clinical, therapeutic values in 
the treatment of acute promyelocytic leukemia (APL) and 
other solid tumors (Yu et al. 2013). As one of the main 
arsenic excretion pathways in the human body, kidney is 
a target organ of arsenic cytotoxicity. Therefore, arsenic 
exposure either from environmental contamination or as a 
result of clinical application may lead to kidney damage, 
including renal failure, proteinuria and increased urinary 
excretion of protein biomarkers for acute kidney injury 
(AKI) (Chen et al. 2011; Soignet et al. 1998; Yu et al. 2013; 
Emadi and Gore 2010). For APL patients with impaired 
renal function, only about 40 % of the excessive plasma 
arsenic from chemotherapeutic regimen could be removed 
by hemodialysis (Yamamoto et al. 2009). Based on recent 
epidemiologic studies in a rural US population, and in 
some regions of China, Taiwan and, especially, in Bangla-
desh, arsenic is a major risk factor for kidney disease and 
arsenic nephrotoxicity should, therefore, receive signifi-
cantly more attention (Chen et al. 2011; Zheng et al. 2013).
The mechanism(s) contributing to arsenic nephrotoxic-
ity are poorly understood. Reactive oxygen species (ROS), 
which are generated during metabolic activation of the met-
alloid, and the ensuring oxidative stress are hypothesized 
to be critical initiating events in arsenic nephrotoxicity 
(Yen et al. 2012). In both AKI and chronic kidney dis-
ease (CKD), oxidative stress and inflammation, which are 
tightly linked, are characteristic features (Ruiz et al. 2013).
Cyclooxygenase-2 (COX-2), a pro-inflammatory, induc-
ible enzyme, has recently been shown to be up-regulated 
after arsenic exposure in human lung fibroblasts (Wang 
et al. 2013b) and human uroepithelial cells (Wang et al. 
2013a). It is well documented that COX-2 plays a key role 
in kidney development and COX-2-derived prostanoids are 
essential in maintaining renal function (Hao and Breyer 
2007). However, to our knowledge, the role of COX-2 in 
arsenic nephrotoxicity has not been previously studied. As 
a redox-sensitive transcription factor, nuclear factor (NF)-
κB regulates COX-2 gene expression in concert with other 
pro-inflammatory and anti-inflammatory factors (Ruiz et al. 
2013).
Previous work from our laboratory has clearly shown 
that mitochondria are an important target of the muta-
genic and metabolic effects of arsenic in mammalian cells 
(Partridge et al. 2007). Recently, arsenic has also been 
reported to induce autophagy (Lau et al. 2013), which is 
an important mechanism regulating cell survival and death 
in connection with mitochondrial functions (Graef and 
Nunnari 2011). We therefore want to further elucidate the 
respective roles and relationship between ROS production, 
autophagy, mitochondrial dysfunction and inflammation in 
arsenic-induced nephrotoxicity, which is not well under-
stood so far.
2,3,5,6-Tetramethylpyrazine (TMP) is a compound 
extracted from the Chinese medicinal plant Ligusticum 
wallichi (Chuanxiong) (Zhai et al. 2012; Wu et al. 2011). 
In addition to vasodilatory and antiplatelet activities, TMP 
also functions as an antioxidant, an anti-inflammatory 
agent and a suppressor of apoptosis (Tang et al. 2013; Zhai 
et al. 2012; Gong et al. 2013). TMP has been reported to 
prevent kidney injury induced by the contrast medium 
iohexol, gentamycin, diabetes and cisplatin (Juan et al. 
2007; Gong et al. 2013). Thus, we hypothesized that TMP 
may suppress arsenic nephrotoxicity. To address this prob-
lem, we have further investigated in the present study the 
regulatory effects of TMP on the pro-inflammatory sign-
aling pathways induced by arsenic treatment and possible 




All chemicals were purchased from Sigma Chemicals (St. 
Louis, Mo., USA) unless otherwise stated. NF-κB inhibitor 
Bay11-7082 was obtained from Calbiochem (La Jolla, CA, 
USA).
Cell culture and treatment
The human proximal tubular cell line (human kidney 2 or 
HK-2) was obtained from the American Type Culture Col-
lection (Manassas, VA, USA) and grown in serum-free 
keratinocyte-cultured medium supplemented with epidermal 
growth factor (5 ng/ml) and bovine extract (50 μg/ml), pen-
icillin and streptomycin at 37 °C in a 5 % CO2 humidified 
environment. About 50 mM stock sodium arsenite was used 
at the final concentrations of 1–10 μM. N-Acetylcysteine 
(NAC 10 mM), TMP (50 μM, 100 μM), Bay (5 μM) and 
SB 203580 (SB, inhibitor of p38 MAPK, 10 μM) were used 
either alone or in combination with arsenic and were added 
into media 30 min before arsenic treatment.
Cell viability analysis
3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazo-
lium (MTT) assay was used to determine cell viability. 
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Briefly, cells were seeded on 96-well plates at a density 
of 5,000 cells/well and cultured at 37 °C for 24 h, before 
exposed to arsenic at concentrations ranging from 1 to 
200 μM for 6, 24 and 48 h. After treatment, the superna-
tant was removed and 100 μl MTT solution (0.5 mg/ml in 
DMEM) was added for a further 3-h incubation at 37 °C. 
Subsequently, crystals were dissolved in DMSO. The 
extent of the reduction of MTT was quantified by measur-
ing absorbance at 550 nm.
TUNEL staining
To determine levels of apoptotic cell death, terminal deoxy-
nucleotidyl transferase-mediated dUTP-biotin nick-end 
labeling (TUNEL) staining was performed using a Click-
iT TUNEL Alexa Fluor 488 Imaging Assay (Invitrogen, 
Grand Island, NY, USA) according to the manufacturer’s 
instructions with the exception that propidium iodide (PI) 
replaced Hoechst 33342 to label all nuclei. Stained nuclei 
were analyzed by a Nikon confocal microscope (Nikon 
TE200-C1) at 24 °C room temperature. TUNEL-positive 
cell numbers from 20 different fields (a total of 2,000–
2,500 cells) were counted to get an average number of 
apoptotic cells per field.
Determination of apoptosis levels and cell cycle analysis 
by fluorescence-activated cell sorter (FACS) assay
After treatment, HK-2 cells were permeabilized in 70 % 
ethanol at 4 °C for at least 24 h. After 30-min staining with 
PI in the dark at 37 °C (Gong et al. 2010), apoptotic level 
and cell cycle distribution were evaluated by FACS (a total 
of 20,000 events were counted). Data were analyzed using 
CellQuest program. Apoptotic levels were calculated by 
evaluating the percentage of cells accumulated in the sub-
G1 position. Samples were analyzed in triplicates, and 
independent experiments were repeated 3 times.
Autophagy detection by immunocytochemical staining 
of LC3B
Autophagy was visualized using LC3B Antibody Kit for 
Autophagy (Invitrogen) according to the manufacturer’s 
instructions. Briefly, cells were grown on glass cover in 
6-well plate and treated with sodium arsenite for 6 h and 
fixed with 3.7 % formaldehyde in PBS and permeabilized 
with 0.2 % Triton X-100 in PBS. Rabbit anti-LC3B primary 
antibody was diluted in blocking buffer (1:500) and incu-
bated 1 h at room temperature. After washing three times 
with PBS, cells were incubated with anti-rabbit secondary 
antibody followed by mounting with PI. Image was cap-
tured using a Nikon confocal microscope (Nikon TE200-
C1) at 24 °C room temperature. Number of autophagosome 
positive cell was counted. In addition, LC3B protein 
expression was measured with Western blotting.
Intracellular ROS and glutathione detection
Dihydroethidium (DHE, Invitrogen, Eugene, OR) was 
used to detect intracellular superoxide production. After 
24 h of sodium arsenite treatment, cells were exposed to 
2 μM DHE for 45 min at 37 °C in the dark. Subsequently, 
cells were washed twice with PBS, and FACS analysis was 
performed using CellQuest program (Becton–Dickinson, 
Franklin Lakes, NJ, USA). Samples were analyzed in trip-
licates, and all experiments were independently repeated 3 
times.
Glutathione (GSH) levels were determined using Glu-
tathione Assay Kit (Sigma, MO, USA) according to the 
manufacturer’s instructions. The yellow product, 5-thio-
2-nitrobenzoic acid (TNB) was measured spectrophoto-
metrically at 412 nm. The assay used a standard curve of 
reduced GSH to determine the amount of GSH in the sam-
ples. Samples were analyzed in triplicates, and all experi-
ments were independently repeated 3 times.
Mitochondrial function assay: cytochrome c oxidase (Cox) 
and succinate dehydrogenase (SDH) histochemistry
Histochemical staining for Cox and SDH was performed 
using previously published method (Salviati et al. 2002). 
Briefly, cells were cultured on glass cover slips inside 
6-well plate. After 6 h of indicated treatment, cells on glass 
cover were allowed to dry at room temperature for 1 h. Fol-
lowing a 15-min preincubation at room temperature with 
1 mM CoCl2 and 50 μl DMSO in 50 mM Tris–HCl, pH 
7.6, containing 10 % sucrose, all samples were rinsed once 
in PBS and incubated for another 3 h with the substrate 
(10 mg cytochrome c, 10 mg of DAB Hydrochloride, 2 mg 
of catalase and 25 μl DMSO dissolved in 10 ml 0.1 M 
sodium phosphate, pH 7.6). After rinsing three times with 
PBS, all samples were mounted on warm glycerin-gelatin 
and observed under Nikon LABOPHOT-2 microscope to 
capture images with SPOT Basic TM software. Quantifica-
tion of histochemical staining was performed with Image 
J software (NIH) and evaluated by two independent and 
blinded investigators. Camera light settings were standard-
ized, and color images were captured with 40× objective.
Mitochondrial membrane potential
Mitochondrial membrane potential was measured using 
Rhodamine 123 staining (Invitrogen) according to the man-
ufacturer’s instructions. Briefly, cells were grown on 6-well 
plate and treated with sodium arsenite for 6 h and then 
stained with Rhodamine 123 (10 μM final concentration 
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in medium) at 37 °C for 30 min. Image was captured with 
a Nikon confocal microscope (Nikon TE200-C1) at 24 °C 
room temperature. Relative fluorescence intensity was 
quantified by Image J software (NIH).
Western blotting
After the various treatments, whole cell lysates were pre-
pared using RIPA buffer (Invitrogen) containing protease 
inhibitors. Nuclear extracts were prepared using meth-
ods described previously (Schreiber et al. 1989). Pro-
tein concentrations were determined with Bio-Rad DC 
protein assay (Bio-Rad Laboratories, CA, USA) using 
bovine serum albumin as a standard. After SDS-PAGE, 
protein samples were transferred to PVDF membrane. 
Primary antibodies used included: rabbit anti-LC3B, rab-
bit anti-PARP1, rabbit anti-pro caspase-9, rabbit anti-
NF-κB, rabbit anti-TNF-α, rabbit anti-β-catenin, rabbit 
anti-p38 MAPK, rabbit anti-phospho-p38 MAPK, rab-
bit anti-histone H3 (Histone) (cell signaling), rabbit anti-
COX-2 (Cayman Chemical) and mouse monoclonal anti-
β-actin (sigma).
Statistical analysis
All data were presented as mean ± SD for a minimum of 
three independent experiments in triplicate. All compari-
sons were made using either one-way ANOVA or a two 
tailed t test analysis depending on how many conditions 
were compared in each experiment. One-way ANOVA was 
followed by Tukey’s post hoc test. A value of p < 0.05 was 
considered significant.
Results
Arsenic-induced dose- and time-dependent cell death 
in HK-2 cells
In our initial experiments on arsenic cytotoxicity in HK-2 
cells, trivalent arsenite (sodium arsenite) and pentavalent 
arsenate (sodium arsenate) were used. Based on determi-
nation of cell viability using MTT assay (Fig. 1a, b), both 
sodium arsenite and sodium arsenate showed a dose- and 
time-dependent cytotoxicity in HK-2 cells. With the same 
dose, trivalent arsenite was found to be more cytotoxic than 
pentavalent arsenate. Indeed, a 10-μM sodium arsenite 
reduced cell viability to 80.6 and 44.5 % at 24 h and 48 h, 
respectively (Fig. 1a). In contrast, a similar dose of sodium 
arsenate resulted in greater than 80 % survival at both time 
points examined. As shown in Fig. 1a, sodium arsenite tox-
icity increased sharply if concentration exceeds 10 μM. 
Given the fact that a dose range of 2.0–10-μM arsenic is 
clinically relevant in the treatment of APL (Ivanov and Hei 
2004, 2005; Shen et al. 1997), we therefore choose this 
dose range for our study.
Fig. 1  TMP prevented 
arsenic-induced cytotoxicity 
and apoptosis in HK-2 cells. a, 
b HK-2 cells were incubated 
with sodium arsenite or sodium 
arsenate at different doses for 
6, 24 or 48 h. Cell viability 
was measured by MTT assay. c 
Apoptosis was determined by 
TUNEL and PI staining. HK-2 
cells were exposed to sodium 
arsenite (0 or 10 μM) 24 h 
alone or in a combination with 
10 mM NAC or 100 μM TMP. 
Merged images were cap-
tured by confocal fluorescent 
microscope at 200× magni-
fication. d Average percent-
ages of TUNEL-positive cells 
were assessed in each group. 
Values are mean ± SD (n = 3), 
*p < 0.05 versus control (Con), 
**p < 0.01 versus Con
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TMP and NAC attenuated arsenic-induced cytotoxicity 
and apoptosis
As shown in Fig. 1a, clinically relevant dosage of sodium 
arsenite caused significant death of HK-2 cells at 48 h; 
therefore, we choose 48 h as the time point to determine 
the protective effects of NAC and TMP against arsenite-
induced cytotoxicity. Figure 2a demonstrated that 10 mM 
NAC and 100 μM TMP pretreatment significantly pro-
tected cells from sodium arsenite (10 μM)-induced cyto-
toxicity. Furthermore, HK-2 cells were cultured in the pres-
ence of 10 mM NAC or 100 μM TMP for 48 h, then MTT 
assay was performed to investigate a potential cytotoxicity 
of 10 mM NAC or 100 μM TMP. The results indicated that 
10 mM NAC and 100 μM TMP were not harmful to HK-2 
cells (data not shown).
In the present study, several approaches were used to 
evaluate arsenic-induced apoptosis in HK-2 cells, such as 
TUNEL staining, cell cycle-apoptosis assay and detection 
of caspase activation followed by PARP cleavage that are 
recognizable markers for apoptosis. A 3.2-fold increase 
in TUNEL-positive cell number was observed 24 h after 
10 μM sodium arsenite treatment (Fig. 1c, d). To further 
assess whether sodium arsenite treatment affected cell 
cycle and induced apoptosis, HK-2 cells were stained 
with PI and analyzed by FACS assay. As shown in Fig. 2, 
exposure to sodium arsenite (2.5–10 μM) significantly 
changed cell cycle distribution and induced apoptosis in 
a dose-dependent manner (Fig. 2a). Additionally, a sig-
nificant down-regulation of pro caspase-9 (that reflected 
its activation) and caspase-3-dependent cleavage of PARP1 
were revealed by Western blotting 24 h after exposure to 
Fig. 2  TMP and NAC inhibited arsenic-induced cytotoxicity and 
apoptosis in HK-2 cells determined with MTT assay, FACS by PI 
staining and Western blotting. a 100 μM TMP and 10 mM NAC pre-
treatment significantly increased cell viability after 48 h exposure to 
10 μM sodium arsenite. b Apoptosis and cell cycle analysis 24 h after 
arsenic treatment with or without NAC (10 mM) or TMP (100 μM) 
pretreatment in HK-2 cells. c Apoptotic rate was calculated by evalu-
ating the percentage of events accumulated in the sub-G1 position. d 
Procaspase-9 protein expression and PARP cleavage were examined 
by Western blotting using β-actin as a loading control. Values are 
mean ± SD (n = 3), *p < 0.05 versus Con, **p < 0.01 versus Con
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sodium arsenite (Fig. 2c). Pretreatment with 100 μM TMP 
or 10 mM NAC efficiently prevented arsenic-induced apop-
tosis in HK-2 cells that was evidenced by the significant 
decrease in TUNEL-positive cell number (Fig. 1c, d) and 
decreased percentage of cells in the apoptotic sub-G1 area 
(Fig. 2a, b).
Arsenic-induced autophagy in the early phase of exposure
We first confirmed the occurrence of autophagy dur-
ing arsenic exposure in human proximal tubular cells. As 
shown by Western blotting analysis in Fig. 3a, the pro-
tein expression of autophagy marker LC3B was markedly 
increased after 6-h arsenic exposure using three differ-
ent concentrations, compared with control cells. Interest-
ingly, such an up-regulation was only detected in the early 
phase, while LC3B protein level was reduced to normal or 
lower 24 h after arsenic exposure (Fig. 3b). Both NAC and 
TMP pretreatment could reverse such an increase in LC3B 
expression levels at 6 h (Fig. 3a, b).
In addition, autophagolysosome formation was detected 
using anti-LC3B staining and confocal fluorescence 
microscopy. Indeed, arsenic exposure (2.5–10 μM) nota-
bly up-regulated LC3B-positive cell number (about 40 % 
increase after 6 h of treatment) (Fig. 3c, d). Similarly to the 
results obtained with analysis of apoptosis, 10 mM NAC 
and 100 μM TMP significantly decreased a number of 
LC3B-positive cells (Fig. 3c, d).
TMP and NAC suppressed arsenic-induced intracellular 
ROS production and enhanced GSH levels
After 24 h treatment with sodium arsenite, the intracellu-
lar ROS production was elevated in a dose-dependent man-
ner (Fig. 4a, b). Quantification of the mean fluorescence 
intensity of images showed that 2.5, 5 and 10 μM sodium 
arsenite at 24 h increased intracellular ROS levels by 1.6-
fold, 2.0-fold and 2.4-fold, respectively, over control levels. 
Furthermore, 3-h exposure to 10 μM sodium arsenite led 
to detectable increase in intracellular ROS production in 
HK-2 cells (Fig. 4c, d). In the presence of NAC (10 mM) 
or TMP (100 μM), the intracellular superoxide production 
induced by 3 h (Fig. 4c, d) or 24 h (Fig. 4e, f) arsenic expo-
sure was significantly reduced (p < 0.05).
As shown in Fig. 4g, the intracellular GSH level was 
diminished about 2-fold after 24-h sodium arsenite treat-
ment in HK-2 cells (p < 0.01 vs. control). However, both 
10 mM NAC and 100 μM TMP pretreatments significantly 
Fig. 3  Arsenic-induced autophagy in HK-2 cells. a, b Arsenic treat-
ment increased LC3B protein expression at 6 h, which dropped at 
24 h. Both TMP (100 μM) and NAC (10 mM) inhibited arsenic-
induced LC3B protein expression. β-Actin was used as loading con-
trol. c, d Induction of autophagy after 6-h arsenic exposure was visu-
alized by LC3B staining (green), which was suppressed by 100 μM 
TMP or 10 mM NAC pretreatment. Values are mean ± SD (n = 3), 
*p < 0.05 versus Con, **p < 0.01 versus Con (color figure online)
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prevented sodium arsenite-induced GSH down-regulation 
(p < 0.05).
TMP and NAC reversed the decreased mitochondrial 
membrane potential induced by sodium arsenite exposure
Using Rhodamine 123 staining, we analyzed changes in 
mitochondrial membrane potential after sodium arsen-
ite treatment of HK-2 cells with or without antioxidant 
co-treatment. As shown in Fig. 5a, b, arsenic treatment 
reduced the mitochondrial membrane potential almost two-
fold; the relative fluorescence intensity of control cells was 
30.2 %, while the 10-μM arsenic treatment reduced this 
level to 14.3 %. Interestingly, NAC and TMP showed sig-
nificant protection of mitochondrial membrane potential in 
arsenite-treated cells resulting in mean fluorescence levels 
of 28.6 and 27.4 %, respectively.
Arsenite-induced mitochondrial dysfunction measured 
by cytochrome c oxidase (Cox) and succinate 
dehydrogenase (SDH) histochemistry
Cytochrome c oxidase (Cox), a subunit of Complex IV 
of the respiratory chain, is composed of both nuclear and 
mitochondrially encoded subunits. Changes in Cox lev-
els indicate the status of mitochondrial respiratory chain 
function. As shown in Fig. 5c, d, sodium arsenite treat-
ment induced a more than fivefold decrease in Cox enzyme 
activity in HK-2 cells that was indicative of mitochondrial 
dysfunction. Compared with Cox, the enzyme activity of 
succinate dehydrogenase (SDH), or complex II, which is 
encoded entirely by nuclear DNA, was not significantly 
impaired by arsenite treatment (Fig. 5e, f). Both NAC 
(10 mM) and TMP (100 μM) prevented a decrease in Cox 
activity while showed minimal effect on SDH (Fig. 5c, f).
Fig. 4  TMP and NAC suppressed arsenic-induced intracellular ROS 
production in HK-2 cells determined by dihydroethidium (DHE) 
staining and FACS analysis. a, b Induction of intracellular ROS gen-
eration in a dose-dependent manner. TMP (100 μM) and NAC (10 
mM) inhibited arsenic-induced ROS generation at 3 (c, d) and 24 h 
(e, f). g Intracellular GSH levels were measured after 24-h sodium 
arsenite exposure. Values are mean ± SD (n = 3), *p < 0.05 versus 
Con, **p < 0.01 versus Con
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Sodium arsenite activated pro-inflammatory signaling 
response, including NF-κB, β-catenin, p38 MAPK 
and their targets COX-2 and TNF-α in HK-2 cells
The critical role of transcription factor NF-κB in regula-
tion of inflammatory response and carcinogenesis, as well 
as in modulating environmental toxicant induced pathogen-
esis has been well established (Baeuerle and Henkel 1994). 
However, arsenic exposure demonstrated distinct, cell-
specific effects on transcription factor NF-κB activation 
(Kumagai and Sumi 2007). In order to explore the precise 
role of arsenite in the activation of NF-κB in HK-2 cells, 
we monitored phospho-NF-κB (Ser536) nuclear protein 
levels after arsenite treatment. As shown in Fig. 6a, b, the 
nuclear NF-κB protein levels were up-regulated in a dose-
dependent manner, as early as 3 h after arsenite exposure, 
further increased at 6 h and partially decreased 24 h after 
treatment. Furthermore, both antioxidant NAC and TMP 
efficiently decreased arsenite-induced nuclear NF-κB acti-
vation in HK-2 cells (Fig. 6a, b) highlighting a role of ROS 
in NF-κB activation. Similarly, β-catenin protein expres-
sion was up-regulated 3 and 6 h after arsenite treatment, but 
then gradually dropped (Fig. 6c, d). Meanwhile, arsenite-
treated HK-2 cells showed an increase in p38 MAPK activ-
ities 6 h after treatment (Fig. 7a, b). TMP and NAC showed 
similar effects on suppressing β-catenin and p38 MAPK 
activation (Figs. 6a, d, 7a, b).
Furthermore, expression of COX-2, a critical pro-
inflammatory protein, was significantly increased at 3 h, 
peaked at 6 h and then dropped to basal level at 24 h after 
sodium arsenite exposure (Fig. 7c, d). TMP and NAC pre-
vented the arsenic-induced COX-2 protein expression 
(Fig. 7c, d). Interestingly, Bay11-7082 (5 μM, a specific 
inhibitor of NF-κB activation) and SB203580 (10 μM, an 
Fig. 5  Pretreatment with 100 μM TMP or 10 mM NAC efficiently 
reversed arsenic-induced mitochondrial dysfunction in HK-2 cells. 
a, b Arsenic decreased mitochondrial membrane potential in HK-2 
cells, while TMP and NAC prevented such a down-regulation. c, 
d Arsenic-induced mitochondrial dysfunction was verified by a 
decreased cytochrome c oxidase (Cox) histochemical staining. 
e, f Succinate dehydrogenase histochemical staining. Values are 
mean ± SD (n = 3), *p < 0.05 versus Con, **p < 0.01 versus Con
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inhibitor of p38 MAPK) blocked arsenic-induced up-reg-
ulation of COX-2 expression at 6 h (Fig. 8a, b), indicating 
that arsenite-induced COX-2 up-regulation was NF-κB and 
p38 MAPK-dependent.
We also tested protein expression of another crucial pro-
inflammatory factor TNF-α 6 h after sodium arsenite expo-
sure. As shown in Fig. 8c, d, TNF-α protein levels were 
obviously up-regulated after 6 h arsenite exposure, while 
TMP and NAC efficiently suppressed such up-regulation of 
TNF-α, highlighting a strong anti-inflammatory functions 
of both antioxidants.
Discussion
In the present study, using a human proximal tubular 
cell line, we examined arsenic-induced nephrotoxicity 
and the corresponding mechanisms. We demonstrated a 
dose-dependent cytotoxicity of arsenic in the HK-2 cell 
model within a clinically relevant dose range of 2–10 μM 
(Ivanov and Hei 2005; Zhao et al. 2008). Our results pro-
vide supporting evidence that arsenite used in the clinic 
for cancer treatment might increase the risk for kidney 
damage. Additionally, our results further suggest that arse-
nic-induced nephrotoxicity is associated with intracellular 
ROS production, mitochondrial dysfunction, activations 
of COX-2 as well as other pro-inflammatory signals and, 
finally, with programed cell death. All these effects of arse-
nic could be suppressed by TMP, a potent antioxidant and 
anti-inflammatory agent extracted from the Chinese Herb, 
Ligusticum wallichi, and by the antioxidant NAC, implying 
that ROS and inflammation played critical roles for medi-
ating arsenic nephrotoxicity. Interestingly, TMP was used 
at substantially lower doses (50–100 μM), compared with 
NAC (10 mM).
Initial experiments were conducted to test the cyto-
toxicity of sodium arsenite and sodium arsenate in HK-2 
cells. Consistent with previous reports (Peraza et al. 2003; 
Ivanov and Hei 2013; Fan et al. 2010; Martin-Pardillos 
et al. 2013), we found that the trivalent arsenite showed 
higher toxicity than the pentavalent arsenate. For sodium 
arsenite, the 10-μM concentration acted as a threshold dose 
for treatment period up to 24 h with increased toxicity fol-
lowing either higher dose or longer treatment time (Fig. 1). 
This finding was consistent with previously studies (Peraza 
et al. 2003; Ivanov et al. 2013). Acute exposure to arsenic 
and other common toxic metals are generally character-
ized by renal tubular necrosis (Eichler et al. 2006). In the 
present study, we demonstrated programed cell death (via 
apoptosis and autophagy) was also critically involved in 
Fig. 6  TMP and NAC inhibited arsenic-induced pro-inflammatory 
signals: NF-κB activation and β-catenin up-regulation in HK-2 cells. 
a, b Arsenic-induced NF-κB activation was determined by increased 
levels of nuclear phospho-Ser536 NF-κB p65, which was inhibited 
by NAC or TMP pretreatment. c, d Arsenic-induced β-catenin up-
regulation was suppressed by NAC and TMP pretreatment. Histone 
H3 (Histon) and β-actin were used as loading controls for nuclear and 
total proteins, respectively
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arsenic-induced nephrotoxicity. Recently, arsenic-induced 
autophagy was observed in human lymphoblastoid cells 
and HEK293 cell line (Bolt et al. 2010; Lau et al. 2013). 
According to our results, autophagy occurred in the early 
phase after arsenic exposure (6 h), which was confirmed by 
increase in the autophagy marker, LC3B protein expression 
and enhanced punctuate dots of a green fluorescent pro-
tein tag of LC3B (Fig. 3a–d). Interestingly, LC3B protein 
expression dropped to basal level at 24 h suggesting that 
autophagy was not consistently induced by arsenic treat-
ment. Results of TUNEL staining, PARP cleavage and 
FACS analysis (Figs. 1, 2) indicated that the cell death at 
24 h mainly through apoptosis. To our best knowledge, this 
is the first study showing arsenic could induce apoptosis, as 
well as autophagy in HK-2 cells.
It still remains very controversial whether autophagy 
is protective or damaging to kidney (Kimura et al. 2010; 
Jiang et al. 2012). Our results showed that arsenic expo-
sure resulted in intracellular superoxide production as early 
as 3 h and in a dose-dependent manner, whereas adminis-
tration of antioxidant NAC efficiently suppressed ROS 
production (Fig. 4c, d), which was accompanied by down-
regulation of apoptosis (Figs. 1, 2) and autophagy (Fig. 3). 
These results indicated that ROS generation was the main 
inducer of HK-2 apoptosis and autophagy after arsenic 
exposure. Based on our current findings, we speculated 
that autophagy as a response of HK-2 cells to the oxidative 
stress in the early phase after arsenic exposure; on the other 
hand, when oxidative stress is under control, autophagy is 
suppressed. This is well correlated with TMP and NAC-
mediated suppression of ROS production and protection 
of HK-2 cells against arsenic cytotoxicity via decreased 
autophagy and apoptosis. Recently, a role of ROS as the 
inducer of autophagy has been reported (Lee et al. 2012). 
Meanwhile, our current findings were consistent with pre-
vious consensus that arsenic-induced cytotoxic effects were 
ROS-dependent (Weng et al. 2013; Srivastava et al. 2013; 
Kumagai and Sumi 2007). It has been demonstrated that 
GSH depletion was deeply involved in arsenic-induced ROS 
production (Yu et al. 2013; Thompson and Franklin 2010). 
In agreement with these reports, decreased GSH levels were 
observed in HK-2 cells after arsenite exposure (Fig. 4g).
Fig. 7  TMP and NAC inhibited arsenic-induced pro-inflammatory 
signals: p38 MAPK activation and COX-2 up-regulation in HK-2 
cells. a, b Arsenic-induced p38 MAPK activation was verified by 
increased levels of phospho-Thr180/Tyr182 p38 MAPK (p-p38) 
expression, which was inhibited by NAC or TMP pretreatment. c, 
d Arsenic up-regulated COX-2 protein expression, while NAC and 
TMP suppressed COX-2 protein up-regulation. β-Actin was used as 
loading control. Values are mean ± SD (n = 3), **p < 0.01 versus 
Con
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Since mitochondria are both the targets for oxidative 
stress and as a rich source of ROS (Burtner et al. 2009; 
Aung-Htut et al. 2013), we hypothesized that mitochon-
drial dysfunction could be involved in arsenic nephrotoxic-
ity. We found that arsenic exposure led to altered mitochon-
drial morphology (data not shown). To gain further insight 
into the relationship between mitochondrial alterations and 
arsenic nephrotoxicity, we analyzed mitochondria function 
by Cox and SDH histochemical assay and by determination 
of mitochondrial membrane potential. After 6-h exposure, 
arsenic resulted in strong loss of mitochondrial membrane 
potential and decreased Cox enzyme activity (Fig. 5a–d), 
which indicated mitochondrial dysfunction. Consistent 
with the function of suppressing ROS, NAC and TMP pre-
treatment protects HK-2 cells against arsenic-induced mito-
chondrial dysfunction (Fig. 5a–d).
Another novel finding of the current study is the demon-
stration that arsenic exposure led to dynamic alterations of 
COX-2 expression in renal tubular epithelial cells. Although 
arsenic-induced activation of inflammatory factor has been 
reported in other cellular systems, the role of inflammation 
in arsenic nephrotoxicity is poorly understood, and there 
are few related data available for arsenic-treated human 
kidney cells (Wang et al. 2012b, 2013a, b; Xu et al. 2013). 
Induction of COX-2 via prostaglandins played a protective 
effect in acute renal failure, and selective COX-2 inhibi-
tion significantly decreased glomerular filtration rate (GFR) 
and renal blood flow, thereby resulting in AKI among salt-
depleted patients (Hao and Breyer 2007; Swan et al. 2000). 
We observed a fast and well-pronounced up-regulation of 
COX-2 protein expression in HK-2 cells after arsenic expo-
sure (Fig. 7c, d). Considering COX-2 function in main-
taining renal function, we therefore speculate that such an 
increase could be self-protective. Interestingly, COX-2 up-
regulation is not continuous, as we observed COX-2 pro-
tein expression dropped to basal level at 24 h after arsenic 
exposure (Fig. 7c, d). TMP and NAC pretreatment reversed 
COX-2 dynamic changes, due to suppression of NF-κB acti-
vation and β-catenin protein expression, the main regula-
tors of COX-2 gene expression (Fig. 6). To our best knowl-
edge, this is the first study showing the dynamic changes of 
COX-2 involved in arsenic-induced nephrotoxicity.
Fig. 8  a, b Arsenic-induced COX-2 up-regulation was NF-κB- and 
p38 MAPK-dependent. Effects of NF-κB inhibitor (Bay11-7082) and 
p38 inhibitor SB203580. c, d Arsenic-induced TNF-α up-regulation 
was suppressed by TMP and NAC pretreatment. β-Actin was used as 
loading control. Values are mean ± SD (n = 3), **p < 0.01 versus 
Con
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We also explored the underlying signal mechanisms in 
modulating arsenic-induced COX-2 activation in HK-2 
cells. As a protein of Wnt signaling pathway, β-catenin 
could act as a transcriptional factor and affect COX-2 tran-
scription (Nunez et al. 2011). Meanwhile, β-catenin was 
reported to play an important role in the carcinogenic activ-
ities of arsenic (Wang et al. 2013c). We observed arsenic 
treatment increased β-catenin expression in the early phase 
(3 h), such up-regulation then gradually dropped to basal 
level (Fig. 6c, d). Correspondingly, arsenic-induced COX-2 
expression occurred at 3 h and returned to normal at 24 h 
(Fig. 7c, d). Recent cancer studies revealed the multiple 
relationships between COX-2 and β-catenin, for example, 
COX-2 acted as mediator to result in enhanced activation 
of β-catenin signaling in nonsmall cell lung cancer cell 
migration (Singh and Katiyar 2013).
Additionally, NF-κB played a key role in pro-inflamma-
tory signal response and acted as a critical target of arse-
nic cytotoxicity in many cell types (Op den Kamp et al. 
2013; Kumagai and Sumi 2007). Previous studies from 
our laboratory and others showed that NF-κB served as 
another upstream regulator of COX-2 (Ruiz et al. 2013; 
Ivanov et al. 2010; Wang et al. 2013b). Our present study 
showed arsenic treatment substantially increased nuclear 
NF-κB protein expression, and such NF-κB activation was 
still observed at 24 h after treatment (Fig. 6a, b). Both NAC 
and TMP pretreatment efficiently reversed arsenic-induced 
nuclear NF-κB protein up-regulation suggesting that arse-
nic acted as an activator of NF-κB through ROS in HK-2 
cell. Similar finding was also reported for many differ-
ent cell systems, including endothelial cells (Wang et al. 
2012b). To further confirm NF-κB as the upstream of COX-
2, NF-κB inhibitor (Bay11-7082) was applied and notably 
blocked arsenic-induced COX-2 expression at 6 h (Fig. 8a).
As an important member of mitogen-activated protein 
kinase (MAPK) family, p38 MAPK was reported to act 
as upstream signal regulating COX-2 expression in nor-
mal human lung fibroblast after arsenic exposure(Wang 
et al. 2013b). Consistent with this report, we also observed 
increased phospho-p38 MAPK expression in HK-2 cells at 
6 h after arsenic treatment. SB203580, an inhibitor of p38 
MAPK, efficiently inhibited COX-2 expression induced by 
arsenic (Fig. 8b).
Furthermore, we detected the effect of arsenic on the 
critical pro-inflammatory regulator TNF-α in HK-2 cells. 
Arsenic treatment effectively enhanced TNF-α protein 
expression (Fig. 8c, d), suggesting that TNF-α also contrib-
uted to arsenic nephrotoxicity in vitro. This is in accord-
ance with the previous report that TNF-α expression was 
elevated in a rat model of arsenic-induced nephrotoxic-
ity (Prabu and Muthumani 2012). Nevertheless, attention 
should be paid to the report that arsenic also acts as an 
anti-inflammatory agent by inhibiting TNF-α in rheumatoid 
arthritis (Mei et al. 2010). Similar interesting but controver-
sial observations were also observed in the effects of arse-
nic on NF-κB activation (Kumagai and Sumi 2007; Mei 
et al. 2010), perhaps reflecting a cell-specific response.
The major finding of our study was the TMP-dependent 
renoprotective effect against arsenic-induced cytotoxic-
ity in HK-2 cells. Such a protection was demonstrated by 
enhanced cellular GSH levels and decreased levels of ROS 
production, autophagy and apoptosis. The mitochondrial 
origin of the protective effects of TMP was further evident 
by its mitigation of arsenic-induced mitochondrial mor-
phology and functional changes. The biological activities of 
TMP showed cell selectivity. Our present findings indicated 
that TMP protected HK-2 cells against arsenic-induced 
apoptosis and on the other hand, TMP was also reported 
to promote arsenic trioxide toxicity and inhibit prolif-
eration in human promyelocytic leukemia cell line HL-60 
(Wu et al. 2012). Such a cell specificity of pro-apoptotic or 
anti-apoptotic effect of TMP was also observed in hepato-
cytes (Zhang et al. 2013). In addition to its anti-apoptotic 
activity, our data also highlighted the anti-inflammatory 
role of TMP in inhibiting a sequence of pro-inflammatory 
signal regulators, including β-catenin, NF-κB, p38 MAPK, 
TNF-α and COX-2. Undoubtedly, the anti-inflammation 
effects of TMP contributed to its protection against arsenic 
nephrotoxicity. The ability of TMP to block p38 MAPK 
activities was consistent with our previous findings in con-
trast-induced nephropathy in vivo (Gong et al. 2013). In 
China, TMP has been widely used in the treatment of renal, 
cardiovascular and cerebral ischemic diseases with a high 
degree of safety (Wang et al. 2012a; Tang et al. 2013; Gong 
et al. 2013). Many clinical and experimental studies have 
revealed that TMP functions as a vasodilator, an anti-coag-
ulant, a free radical scavenger and a suppressor of inflam-
mation and apoptosis (Wang et al. 2012a; Toth et al. 2013; 
Kao et al. 2013) .
In summary, the present study suggests that arsenic 
treatment at clinically relevant dose results in renal toxic-
ity based on observation made in a human renal tubular 
epithelial cell model. Furthermore, such cell damage is 
complex, besides the known necrosis, involving apoptosis 
and autophagy; there is involvement of oxidative stress, 
pro-inflammatory signal activation and mitochondrial dys-
function as well. Finally, TMP efficiently prevents arsenic-
induced nephrotoxicity in vitro by reversing these patho-
logical processes and thus may prove beneficial in patients 
at high risk for arsenic-induced nephrotoxicity.
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